QHM-2025-8314 A87017.99C..01

01". This contract focuses on health service provisions such as PSA Monitoring, Diabetes Care Planning, and Shared Care Drug Monitoring, primarily taking place in the UKC region. The process is currently at the award stage as of 11th October 2025, with the active contract set to begin on 1st April 2025 and conclude on 31st March 2026.

The procurement is conducted through a limited method, specifically under the Direct Award Process A of the Health Care Services (Provider Selection Regime) regulations 2023, rendering some traditional procurement regulations inapplicable. The existing provider, Woodlands Park Health Centre, has been selected without a competitive bidding process due to a lack of realistic alternative providers. This tender offers substantial growth opportunities for businesses in the health services industry, particularly those specialising in handling PSA monitoring, diabetes care, and shared care drug monitoring.

While the tender is structured as an activity-based contract with no guaranteed value, it suits established providers capable of delivering consistent service quality. Large-scale health service providers, particularly those familiar with NHS operations and regulations, will find this opportunity well-suited to their capabilities. Additionally, the tender's focus on direct awards under specified regulations highlights a niche growth area for businesses aiming to engage with public health contracts across the region.